Clinical Trials

Find a Trial

Trial Results

12 protocol(s) meet the specified criteria
A011104OPEN TO ACCRUAL
Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women with Breast Cancer
A011202OPEN TO ACCRUAL
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
A011401OPEN TO ACCRUAL
RANDOMIZED PHASE III TRIAL EVALUATING THE ROLE OF WEIGHT LOSS IN ADJUVANT TREATMENT OF OVERWEIGHT AND OBESE WOMEN WITH EARLY BREAST CANCER
A011502OPEN TO ACCRUAL
A RANDOMIZED PHASE III DOUBLE BLINDED PLACEBO CONTROLLED TRIAL OF ASPIRIN AS ADJUVANT THERAPY FOR NODE POSTIVE HER2 NEGATIVE BREAST CANCER: THE ABC TRIAL
CP-MGAH22-04OPEN TO ACCRUAL
A Phase 3, Randomized Study of Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of Patients with HER2+ Metastatic Breast Cancer Who Have Received Prior Anti-HER2 Therapies and Require Systemic Treatment
EAY131-L/MATCHOPEN TO ACCRUAL
MATCH Treatment Subprotocol L: Phase II Study of MLN0128 (TAK-228) in Patients with Tumors with mTOR Mutations
EAY131-M/MATCHOPEN TO ACCRUAL
MATCH Treatment Subprotocol M: Phase II Study of MLN0128 (TAK-228) in Patients with Tumors with TSC1 or TSC2 Mutations
EAY131-Z1E/MATCHOPEN TO ACCRUAL
MATCH Treatment Subprotocol Z1E: LOXO-101 in Patients with Tumors with NTRK Fusions
NRG-GI001OPEN TO ACCRUAL
Randomized Phase III Study of Focal Radiation Therapy for Unresectable, Localized Intrahepatic Cholangiocarcinoma
NSABP-B-51OPEN TO ACCRUAL
A Randomized Phase III Clinical Trial Evaluating post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotehrapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy.
RTOG-0848OPEN TO ACCRUAL
A Phase II-R and A Phase III Trial Evaluating Both Erlotinib (PH II-R) and Chemoradiation (PHIII) as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma
TBCRC040OPEN TO ACCRUAL
Plasma Tumor DNA and Pathologic Complete Response in Early-Stage, High-Risk Breast Cancer